From: Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer
ADC
Antibody
Linker
Payload
ABT-414
ABT-806
mc (non-cleavable)
MMAF
AB095-MMAF
AB095
ABBV-321
ABT-806 AM1
mc-VC (cleavable)
PBD
AB095-PBD